The inauguration was attended by the Prime Minister of the country, Mr. Edi Rama, accompanied by senior officials for the Minister of Economy, Culture and Innovation. During this ceremony, Mr. Kristian Lekli, in his capacity as the Vice President of the company, presented the Prime Minister with the personalized engraved symbol of the Factory's foundations.
Located within a 75,000 square meter industrial zone, the facility covers a constructed area of 3,000 square meters, embodying LEKLI sh.p.k.’s long-term vision for sustainable development and high-quality standards in pharmaceutical production.
Equipped with cutting-edge technology and fully compliant with Good Manufacturing Practices (GMP), the factory ensures high quality at every stage of the production process - from formulation to the final product.
The facility manufactures personalized medicines, orphan drugs for rare diseases, and cytostatic medications, addressing critical healthcare needs in Albania and the region. The company specializes in the production of oral solid and liquid dosage forms for internal use.
The Quality Assurance and Quality Control (QA/QC) laboratories have been built according to the highest international standards, in full compliance with Good Laboratory Practices (GLP) and ISO/IEC 17025 guidelines, ensuring safety, efficacy, and reliability throughout the entire production chain.
Led by a professional and visionary management team, the company aims to build strong bridges between science, technology, and sustainable development—opening new horizons in the field of pharmaceutical sciences.
The inauguration of LEKLI SCIENCES marks a new milestone in the company’s journey, positioning LEKLI sh.p.k. as a key player in the pharmaceutical industry in Albania and the wider region.
ABOUT LEKLI sh.p.k.
LEKLI sh.p.k. is a pharmaceutical company focused on market research and manufacture of medical products for human use. Our experience in pharmaceuticals began in 1986 and resulted in the establishment of LEKLI sh.p.k. in 1991 by Dr. Luan Lekli. During these years, LEKLI sh.p.k. managed to grow from a well-established pharmaceutical company to one with cross-border presence.
In the following years, we specialized in the field of rare diseases, leading the market and making sure that every single patient is able to live a better life. In 2015, LEKLI sh.p.k. established a production facility, manufacturing generic drugs, phytotherapeutics and orphan drugs. To cover all the needs of the Albanian market, we produce prescription, non-prescription, extemporaneous, and stock pharmaceutical preparations.
Our experience spans more than 25 years in the Balkan market, during which we have established our presence through our operations in Albania and in Kosovo. Today we have strong brand equity and awareness. Together with our highly motivated, experienced and empowered management team we lead the market in special indication areas.
LEKLI disclaims any obligation to update the information contained in this press release as new information becomes available.
LEKLI sh.p.k.:
Kristian Lekli, +355 69 720 3644
David Lekli, +355 69 833 4620
Shpend Hasani, +383 44 197 654 (Kosovo)
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Back